Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial Function
- 10 May 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 258 (2) , 431-435
- https://doi.org/10.1006/bbrc.1999.0648
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Dependence of Augmentation of Arterial Endothelial Cell Expression of Plasminogen Activator Inhibitor Type 1 by Insulin on Soluble Factors Released From Vascular Smooth Muscle CellsCirculation, 1997
- Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.Journal of Clinical Investigation, 1997
- Intracellular Calcium Mobilization Suppresses the TNF-α–Stimulated Synthesis of PAI-1 in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patientsDiabetologia, 1996
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and
C57BL KsJ-db db Metabolism, 1995 - Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.Proceedings of the National Academy of Sciences, 1992